Related Experiment Video
Updated: Oct 2, 2026

The CYP2D6 Animal Model: How to Induce Autoimmune Hepatitis in Mice
Published on: February 3, 2012
Adverse effects of mouse hepatitis virus on ascites myeloma passage in the BALB/eJ mouse
Abstract:
During experimental serial passage of ascites myelomas through BALB/cJ mice, unexpected illness and premature deaths occurred. Postmortem examination of affected mice revealed focal or diffuse discolored depressed areas in the liver and, in some cases, splenomegaly. Histopathologic findings consisted of focal to diffuse areas of necrosis with minimal leukocytic infiltration. Aerobic and anaerobic bacterial cultures of livers and spleens from affected mice were negative. Mouse hepatitis virus (MHV) was isolated from livers of clinically ill mice and from the ascites myeloma lines. An MHV contaminated ascites myeloma line, when passed into nude (nu/nu) mice, killed the animals in 6 days; the virus was isolated from livers of inoculated mice. Attempts to determine the source of the infection were unsuccessful. Serologic survey of newly acquired mice indicated no evidence of antibodies to MHV while mice in holding rooms had titers that ranged from 1:10 to 1:40. Two solid myeloma lines (being maintained by subcutaneous passage) were negative for MHV when tested by virus isolation techniques, and nine lines were negative to 11 murine viruses when tested by mouse antibody production assay. Attempts to demonstrate Eperythrozoon coccoides in control BALB/cJ mice were unsuccessful. Because of the outbreak, changes were made in animal handling procedures. A colony of BALB/cAn mice negative to MHV antibodies was established to provide animals for experimental passage of tumors, and animals in both the breeding and transfer room were placed under filter tops. The results were encouraging. In the four newly established tumor lines, one having been passed 46 times, no illness or unexplained deaths were observed.
Insights
Mouse hepatitis virus (MHV) caused unexpected deaths in mice during tumor passage. Implementing enhanced animal handling procedures and using MHV-negative mice prevented further outbreaks and ensured experimental integrity.
Area of Science:
- Veterinary Pathology
- Virology
- Animal Models
Background:
- Experimental serial passage of ascites myelomas in BALB/cJ mice led to unexpected morbidity and mortality.
- Affected mice exhibited liver necrosis and splenomegaly, with negative bacterial cultures.
Purpose of the Study:
- To identify the cause of unexpected deaths during experimental tumor passage.
- To implement strategies to prevent future outbreaks and ensure animal model reliability.
Main Methods:
- Virus isolation from affected mice and myeloma lines.
- Serologic surveys to assess MHV antibody prevalence.
- Mouse antibody production assay for other murine viruses.
- Implementation of modified animal handling procedures and use of MHV-negative mice.
Main Results:
- Mouse hepatitis virus (MHV) was isolated from sick mice and contaminated ascites myeloma lines.
- MHV infection proved lethal in nude mice, confirming its pathogenicity.
- MHV antibodies were detected in mice from holding rooms, indicating a potential source.
- Modified procedures and MHV-negative mice successfully prevented illness in new tumor lines.
Conclusions:
- Mouse hepatitis virus (MHV) was the causative agent of the outbreak during experimental tumor passage.
- Enhanced animal husbandry, including the use of MHV-seronegative mice and improved housing, is critical for maintaining healthy animal models.

